![Corrigendum] Metoprolol and bisoprolol ameliorate hypertrophy of neonatal rat cardiomyocytes induced by high glucose via the PKC/NF‑κB/c‑fos signaling pathway Corrigendum] Metoprolol and bisoprolol ameliorate hypertrophy of neonatal rat cardiomyocytes induced by high glucose via the PKC/NF‑κB/c‑fos signaling pathway](https://www.spandidos-publications.com/article_images/etm/23/3/etm-23-03-11134-g01.jpg)
Corrigendum] Metoprolol and bisoprolol ameliorate hypertrophy of neonatal rat cardiomyocytes induced by high glucose via the PKC/NF‑κB/c‑fos signaling pathway
![Evaluation of the dose-related concentration approach in therapeutic drug monitoring of diuretics and β-blockers – drug classes with low adherence in antihypertensive therapy | Scientific Reports Evaluation of the dose-related concentration approach in therapeutic drug monitoring of diuretics and β-blockers – drug classes with low adherence in antihypertensive therapy | Scientific Reports](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41598-019-52164-y/MediaObjects/41598_2019_52164_Fig1_HTML.png)
Evaluation of the dose-related concentration approach in therapeutic drug monitoring of diuretics and β-blockers – drug classes with low adherence in antihypertensive therapy | Scientific Reports
![Spironolactone versus placebo, bisoprolol, and doxazosin to determine the optimal treatment for drug-resistant hypertension (PATHWAY-2): a randomised, double-blind, crossover trial - The Lancet Spironolactone versus placebo, bisoprolol, and doxazosin to determine the optimal treatment for drug-resistant hypertension (PATHWAY-2): a randomised, double-blind, crossover trial - The Lancet](https://www.thelancet.com/cms/attachment/92c78bdc-c776-4547-8c9f-25d568de4172/gr1_lrg.gif)
Spironolactone versus placebo, bisoprolol, and doxazosin to determine the optimal treatment for drug-resistant hypertension (PATHWAY-2): a randomised, double-blind, crossover trial - The Lancet
![Temporal haemodynamic changes after bisoprolol treatment in patients with uncontrolled hypertension - Zeng - Annals of Translational Medicine Temporal haemodynamic changes after bisoprolol treatment in patients with uncontrolled hypertension - Zeng - Annals of Translational Medicine](https://cdn.amegroups.cn/journals/amepc/files/journals/16/articles/71751/public/71751-PB6-9658-R1.png/w300)
Temporal haemodynamic changes after bisoprolol treatment in patients with uncontrolled hypertension - Zeng - Annals of Translational Medicine
![Biowaiver Monograph for Immediate-Release Solid Oral Dosage Forms: Bisoprolol Fumarate - Journal of Pharmaceutical Sciences Biowaiver Monograph for Immediate-Release Solid Oral Dosage Forms: Bisoprolol Fumarate - Journal of Pharmaceutical Sciences](https://jpharmsci.org/cms/attachment/2046471193/2057549842/gr1.jpg)
Biowaiver Monograph for Immediate-Release Solid Oral Dosage Forms: Bisoprolol Fumarate - Journal of Pharmaceutical Sciences
![Catalysts | Free Full-Text | Chemoenzymatic Protocol for the Synthesis of Enantiopure β-Blocker (S)-Bisoprolol Catalysts | Free Full-Text | Chemoenzymatic Protocol for the Synthesis of Enantiopure β-Blocker (S)-Bisoprolol](https://www.mdpi.com/catalysts/catalysts-13-00054/article_deploy/html/images/catalysts-13-00054-g001-550.jpg)